REVISTA DESTACADA

Manejo del dolor neuropático en perros

Valoración Valoración: 4 Estrellas

Descripción: Revisión de los mecanismos fisiopatológicos del dolor neuropático y sus posibles tratamientos

TITULO FUENTE ORIGINAL:

Managing Neuropathic Pain in Dogs

AUTORES:

Sarah A. M.

REVISTA ABREV.:

Front Vet Sci

AÑO:

2016

REFERENCIA:

3: 12

DOI:

10.3389/fvets.2016.00012

RESUMEN ORIGINAL:

Disorders of the somatosensory system such as neuropathic pain are common in people with chronic neurologic and musculoskeletal diseases, yet these conditions remain an underappreciated morbidity in veterinary patients. This is likely because assessment of neuropathic pain in people relies heavily on self-reporting, something our veterinary patients are not able to do. The development of... + Leer más

Disorders of the somatosensory system such as neuropathic pain are common in people with chronic neurologic and musculoskeletal diseases, yet these conditions remain an underappreciated morbidity in veterinary patients. This is likely because assessment of neuropathic pain in people relies heavily on self-reporting, something our veterinary patients are not able to do. The development of neuropathic pain is a complex phenomenon, and concepts related to it are frequently not addressed in the standard veterinary medical curriculum such that veterinarians may not recognize this as a potential problem in patients. The goals of this review are to discuss basic concepts in the pathophysiology of neuropathic pain, provide definitions for common clinical terms used in association with the condition, and discuss pharmacological treatment options for dogs with neuropathic pain. The development of neuropathic pain involves key mechanisms such as ectopic afferent nerve activity, peripheral sensitization, central sensitization, impaired inhibitory modulation, and pathologic activation of microglia. Treatments aimed at reducing neuropathic pain are targeted at one or more of these mechanisms. Several drugs are commonly used in the veterinary clinical setting to treat neuropathic pain. These include gabapentin, pregabalin, amantadine, and amitriptyline. Proposed mechanisms of action for each drug, and known pharmacokinetic profiles in dogs are discussed. Strong evidence exists in the human literature for the utility of most of these treatments, but clinical veterinary-specific literature is currently limited. Future studies should focus on objective methods to document neuropathic pain and monitor response to therapy in veterinary patients.

- Leer menos

COMENTARIO DE IGNACIO, ?LVAREZ G?MEZ DE SEGURA

Esta revisión revisa la fisiopatología y los aspectos básicos del dolor neuropático y revisa las definiciones y conceptos relevantes, así como los principales tratamientos que incluyen gabapentina, pregabalina, amantadina, y amitriptilina. Desgraciadamente se resalta la poca información científica de carácter clínico disponible en... + Leer más

Esta revisión revisa la fisiopatología y los aspectos básicos del dolor neuropático y revisa las definiciones y conceptos relevantes, así como los principales tratamientos que incluyen gabapentina, pregabalina, amantadina, y amitriptilina. Desgraciadamente se resalta la poca información científica de carácter clínico disponible en animales de compañía.

- Leer menos

ENLACES DE INTERÉS

Descarga gratuita: http://journal.frontiersin.org/article/10.338[...]

Enlace al texto completo: : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC[...]